Where AI and molecular testing are showing new methods of detecting pancreatic cancers before they become more advanced.
Research team identifies five disease cohort categories for which voice changes have been associated with specific diseases with well-recognized unmet needs.
Watching a new set of genes for ALS treatment connections, using remote sleep monitoring for detecting Parkinson’s breathing patterns, plus a major investment.
More states are focusing on cancer biomarker testing for payer coverage requirements.
New microbiome study shows that genes impact what types of bacteria are present in the intestines, creating new implications for neurological and emotional health.
Recent research into liquid biopsies has resulted in a new blood test that can detect liver cancer while it is still in an early stage.
Diagnostic yield in larger gene panel testing, ambitious goals for gene editing, and gauging demand for genetic testing in the community.
Several recent advances in wearable technologies may mean that healthcare leaders are getting closer to seeing wearables as a core part of precision medicine.
After a multimillion-dollar investment of public funding for early implementation of rapid whole genome sequencing (rWGS), those at the forefront release progress.
American College of Physicians (ACP) offers guidance on genetic testing. DOJ announces first prosecutions for fraudulent cardiovascular genetic testing.